# Tier 5 Enumeration: Respiratory Medications

> **Location in Hierarchy**:
> Tier 1: Medical > Tier 2: Medications > Tier 3: Prescription Medications > Tier 4: Respiratory Medications > **Tier 5: Individual Cards**

---

## Overview

This document enumerates ALL individual Tier 5 cards for Respiratory Medications. Each entry represents ONE SMART card with titratable doses handled within a single card.

**Total Estimated Cards**: ~40 cards

---

## Tier 4: Short-Acting Beta-Agonists (SABA)

| Card ID | Card Name | Common Doses | Primary Use |
|---------|-----------|--------------|-------------|
| MED_RESP_SABA_001 | Albuterol MDI (ProAir, Ventolin, Proventil) | 1-2 puffs q4-6h PRN | Acute bronchospasm (Asthma, COPD) |
| MED_RESP_SABA_002 | Albuterol Nebulizer Solution | 2.5mg q4-6h PRN | Acute bronchospasm (severe) |
| MED_RESP_SABA_003 | Levalbuterol MDI (Xopenex) | 1-2 puffs q4-6h PRN | Acute bronchospasm (R-isomer only) |
| MED_RESP_SABA_004 | Levalbuterol Nebulizer Solution | 0.63-1.25mg q6-8h PRN | Acute bronchospasm |

**Subtotal: 4 cards**

---

## Tier 4: Short-Acting Muscarinic Antagonists (SAMA)

| Card ID | Card Name | Common Doses | Primary Use |
|---------|-----------|--------------|-------------|
| MED_RESP_SAMA_001 | Ipratropium MDI (Atrovent HFA) | 2 puffs QID | COPD maintenance, acute bronchospasm |
| MED_RESP_SAMA_002 | Ipratropium Nebulizer Solution | 0.5mg q6-8h | COPD, acute bronchospasm |

**Subtotal: 2 cards**

---

## Tier 4: SABA/SAMA Combinations

| Card ID | Card Name | Common Doses | Primary Use |
|---------|-----------|--------------|-------------|
| MED_RESP_COMBO_001 | Albuterol/Ipratropium MDI (Combivent Respimat) | 1 puff QID | COPD |
| MED_RESP_COMBO_002 | Albuterol/Ipratropium Nebulizer (DuoNeb) | 3mL q6h | COPD exacerbation |

**Subtotal: 2 cards**

---

## Tier 4: Inhaled Corticosteroids (ICS)

| Card ID | Card Name | Common Doses | Primary Use |
|---------|-----------|--------------|-------------|
| MED_RESP_ICS_001 | Fluticasone Propionate MDI (Flovent HFA) | 44-440mcg BID | Asthma maintenance |
| MED_RESP_ICS_002 | Fluticasone Propionate DPI (ArmonAir RespiClick) | 55-232mcg BID | Asthma maintenance |
| MED_RESP_ICS_003 | Budesonide DPI (Pulmicort Flexhaler) | 180-360mcg BID | Asthma maintenance |
| MED_RESP_ICS_004 | Budesonide Nebulizer (Pulmicort Respules) | 0.25-1mg daily-BID | Pediatric asthma |
| MED_RESP_ICS_005 | Beclomethasone MDI (QVAR RediHaler) | 40-320mcg BID | Asthma maintenance |
| MED_RESP_ICS_006 | Mometasone DPI (Asmanex) | 110-440mcg daily-BID | Asthma maintenance |
| MED_RESP_ICS_007 | Ciclesonide MDI (Alvesco) | 80-320mcg BID | Asthma maintenance |

**Subtotal: 7 cards**

---

## Tier 4: Long-Acting Beta-Agonists (LABA)

| Card ID | Card Name | Common Doses | Primary Use |
|---------|-----------|--------------|-------------|
| MED_RESP_LABA_001 | Salmeterol DPI (Serevent Diskus) | 50mcg BID | Asthma/COPD (must use with ICS for asthma) |
| MED_RESP_LABA_002 | Formoterol DPI (Foradil) | 12mcg BID | Asthma/COPD |
| MED_RESP_LABA_003 | Formoterol Nebulizer (Perforomist) | 20mcg BID | COPD |
| MED_RESP_LABA_004 | Olodaterol (Striverdi Respimat) | 2.5mcg daily | COPD |
| MED_RESP_LABA_005 | Indacaterol (Arcapta Neohaler) | 75mcg daily | COPD |
| MED_RESP_LABA_006 | Arformoterol (Brovana) | 15mcg BID | COPD |

**Subtotal: 6 cards**

---

## Tier 4: Long-Acting Muscarinic Antagonists (LAMA)

| Card ID | Card Name | Common Doses | Primary Use |
|---------|-----------|--------------|-------------|
| MED_RESP_LAMA_001 | Tiotropium (Spiriva HandiHaler/Respimat) | 18mcg daily / 2.5mcg daily | COPD, Asthma (add-on) |
| MED_RESP_LAMA_002 | Umeclidinium (Incruse Ellipta) | 62.5mcg daily | COPD |
| MED_RESP_LAMA_003 | Aclidinium (Tudorza Pressair) | 400mcg BID | COPD |
| MED_RESP_LAMA_004 | Glycopyrrolate DPI (Seebri Neohaler) | 15.6mcg BID | COPD |
| MED_RESP_LAMA_005 | Revefenacin (Yupelri) | 175mcg daily (nebulizer) | COPD |

**Subtotal: 5 cards**

---

## Tier 4: ICS/LABA Combinations

| Card ID | Card Name | Common Doses | Primary Use |
|---------|-----------|--------------|-------------|
| MED_RESP_ICSLABA_001 | Fluticasone/Salmeterol (Advair Diskus/HFA) | 100/50 - 500/50mcg BID | Asthma, COPD |
| MED_RESP_ICSLABA_002 | Budesonide/Formoterol (Symbicort) | 80/4.5 - 160/4.5mcg BID | Asthma, COPD |
| MED_RESP_ICSLABA_003 | Mometasone/Formoterol (Dulera) | 100/5 - 200/5mcg BID | Asthma |
| MED_RESP_ICSLABA_004 | Fluticasone Furoate/Vilanterol (Breo Ellipta) | 100/25 - 200/25mcg daily | Asthma, COPD |

**Subtotal: 4 cards**

---

## Tier 4: LAMA/LABA Combinations

| Card ID | Card Name | Common Doses | Primary Use |
|---------|-----------|--------------|-------------|
| MED_RESP_LAMALABA_001 | Umeclidinium/Vilanterol (Anoro Ellipta) | 62.5/25mcg daily | COPD |
| MED_RESP_LAMALABA_002 | Tiotropium/Olodaterol (Stiolto Respimat) | 2.5/2.5mcg daily | COPD |
| MED_RESP_LAMALABA_003 | Glycopyrrolate/Formoterol (Bevespi Aerosphere) | 9/4.8mcg BID | COPD |
| MED_RESP_LAMALABA_004 | Aclidinium/Formoterol (Duaklir Pressair) | 400/12mcg BID | COPD |

**Subtotal: 4 cards**

---

## Tier 4: Triple Therapy (ICS/LAMA/LABA)

| Card ID | Card Name | Common Doses | Primary Use |
|---------|-----------|--------------|-------------|
| MED_RESP_TRIPLE_001 | Fluticasone/Umeclidinium/Vilanterol (Trelegy Ellipta) | 100/62.5/25mcg daily | COPD, Asthma |
| MED_RESP_TRIPLE_002 | Budesonide/Glycopyrrolate/Formoterol (Breztri Aerosphere) | 160/9/4.8mcg BID | COPD |

**Subtotal: 2 cards**

---

## Tier 4: Leukotriene Modifiers

| Card ID | Card Name | Common Doses | Primary Use |
|---------|-----------|--------------|-------------|
| MED_RESP_LEUK_001 | Montelukast (Singulair) | 10mg daily (adults) | Asthma, Allergic rhinitis |
| MED_RESP_LEUK_002 | Zafirlukast (Accolate) | 20mg BID | Asthma |
| MED_RESP_LEUK_003 | Zileuton (Zyflo) | 600mg QID or 1200mg BID (CR) | Asthma |

**Subtotal: 3 cards**

---

## Tier 4: Methylxanthines

| Card ID | Card Name | Common Doses | Primary Use |
|---------|-----------|--------------|-------------|
| MED_RESP_METH_001 | Theophylline ER | 200-600mg BID | COPD adjunct (narrow TI, monitor levels) |

**Subtotal: 1 card**

---

## Tier 4: Biologics for Asthma

| Card ID | Card Name | Common Doses | Primary Use |
|---------|-----------|--------------|-------------|
| MED_RESP_BIO_001 | Omalizumab (Xolair) | 150-375mg q2-4wk SQ | Allergic asthma (IgE) |
| MED_RESP_BIO_002 | Mepolizumab (Nucala) | 100mg q4wk SQ | Severe eosinophilic asthma |
| MED_RESP_BIO_003 | Benralizumab (Fasenra) | 30mg q4wk x3, then q8wk SQ | Severe eosinophilic asthma |
| MED_RESP_BIO_004 | Dupilumab (Dupixent) | 200-300mg q2wk SQ | Moderate-severe asthma, eosinophilic |
| MED_RESP_BIO_005 | Tezepelumab (Tezspire) | 210mg q4wk SQ | Severe asthma (any phenotype) |

**Subtotal: 5 cards**

---

## Tier 4: Phosphodiesterase-4 (PDE4) Inhibitors

| Card ID | Card Name | Common Doses | Primary Use |
|---------|-----------|--------------|-------------|
| MED_RESP_PDE4_001 | Roflumilast (Daliresp) | 500mcg daily | COPD (reduce exacerbations) |

**Subtotal: 1 card**

---

## Summary

| Tier 4 Category | Card Count |
|-----------------|------------|
| Short-Acting Beta-Agonists (SABA) | 4 |
| Short-Acting Muscarinic Antagonists (SAMA) | 2 |
| SABA/SAMA Combinations | 2 |
| Inhaled Corticosteroids (ICS) | 7 |
| Long-Acting Beta-Agonists (LABA) | 6 |
| Long-Acting Muscarinic Antagonists (LAMA) | 5 |
| ICS/LABA Combinations | 4 |
| LAMA/LABA Combinations | 4 |
| Triple Therapy (ICS/LAMA/LABA) | 2 |
| Leukotriene Modifiers | 3 |
| Methylxanthines | 1 |
| Biologics for Asthma | 5 |
| PDE4 Inhibitors | 1 |
| **TOTAL** | **46 cards** |

---

## Card Naming Convention

**Format**: `MED_RESP_[SUBCLASS]_[NUMBER]`

**Subclass Abbreviations**:
- `SABA` = Short-Acting Beta-Agonists
- `SAMA` = Short-Acting Muscarinic Antagonists
- `COMBO` = SABA/SAMA Combinations
- `ICS` = Inhaled Corticosteroids
- `LABA` = Long-Acting Beta-Agonists
- `LAMA` = Long-Acting Muscarinic Antagonists
- `ICSLABA` = ICS/LABA Combinations
- `LAMALABA` = LAMA/LABA Combinations
- `TRIPLE` = Triple Therapy
- `LEUK` = Leukotriene Modifiers
- `METH` = Methylxanthines
- `BIO` = Biologics
- `PDE4` = PDE4 Inhibitors

**Examples**:
- `MED_RESP_SABA_001` = Albuterol MDI
- `MED_RESP_ICSLABA_001` = Fluticasone/Salmeterol (Advair)
- `MED_RESP_BIO_001` = Omalizumab (Xolair)

---

## Notes

1. **Titratable doses within single card**: Each card covers full dose range
2. **Inhaler devices matter**: Same drug in different devices (MDI vs DPI vs Respimat) may have different dosing but kept as one card where clinically similar
3. **Brand names included**: Listed in parentheses for common recognition
4. **Asthma step therapy**: Cards will reference GINA/NAEPP step therapy in clinical details
5. **COPD GOLD guidelines**: Cards will reference GOLD group classifications
6. **Not included**: Nebulized antibiotics (Tobramycin, etc.) - see Antibiotics category; Cough/cold medications - see OTC category

---

## Clinical Pearls for Card Development

When developing individual cards, ensure:

1. **SABA Cards**: Include "rescue" terminology, max daily puffs, signs of overuse indicating poor control
2. **ICS Cards**: Include rinse-and-spit instructions, growth monitoring in children, systemic effects with high doses
3. **LABA Cards**: NEVER use alone for asthma (black box warning) - must pair with ICS
4. **LAMA Cards**: Contraindicated in narrow-angle glaucoma, urinary retention
5. **Biologic Cards**: Include injection site reactions, anaphylaxis monitoring, step-down potential
6. **Montelukast Cards**: Include neuropsychiatric warnings (suicidality, mood changes)
7. **All Inhalers**: Include proper technique, spacer use, and "check" frequency for devices

---

*Version 1.0 | Created: 2024-11-23*
*Source: LIBRARY_TIER_STRUCTURE.md*
